» Articles » PMID: 31808910

Sickle Cell Disease: a Comprehensive Program of Care from Birth

Overview
Specialty Hematology
Date 2019 Dec 7
PMID 31808910
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

As more children are appropriately being diagnosed, the burden of sickle cell disease is increasing greatly in Africa and in high-resource countries such as the United States and Europe. Early management is mandatory, but newborn screening is not implemented everywhere. Point-of-care testing devices are increasingly being used in low-resource countries, showing good sensitivity and specificity. Because the diagnosis is often traumatic for the families, the announcement should be made by an experienced person. The development of care networks is urgently required to facilitate daily life by defining the respective functions of nearby and highly specialized health care professionals, who should work in close collaboration. Comprehensive programs targeting the prevention of pneumococcal infections, malaria in infested zones, and stroke may substantially improve patient care. Hydroxyurea is increasingly being used, but whether it should be systematically prescribed in all children is debated, and its access is still limited in many African countries. Yearly checkups should be organized early in life in order to screen and then treat any organ impairment. Enhancing parents' and patients' knowledge and skills is mandatory.

Citing Articles

Hydroxyurea for Malignant Pertussis in Critically Ill Children.

Blanc M, Marais C, Debs A, Cousin V, Tissieres P Crit Care Explor. 2025; 7(2):e1218.

PMID: 39937591 PMC: 11826043. DOI: 10.1097/CCE.0000000000001218.


Sickle cell disease awareness and perception among Christian religious leaders in Accra Metropolis: a qualitative study.

Okyere R, Ampomah M, Achempim-Ansong G, Laari L, Ohene L, Atkin K J Community Genet. 2024; 15(6):641-652.

PMID: 39358664 PMC: 11645390. DOI: 10.1007/s12687-024-00738-3.


Social Vulnerability and Sickle Cell Disease Mortality in the US.

Tan J, San B, Yeo Y, Chan K, Shaaban H, Ezekwudo D JAMA Netw Open. 2024; 7(9):e2440599.

PMID: 39348116 PMC: 11443353. DOI: 10.1001/jamanetworkopen.2024.40599.


Effect of nutritional supplementation on bone mineral density in children with sickle cell disease: protocol for an open-label, randomised controlled clinical trial.

Conde M, Lespessailles E, Wanneveich M, Allemandou D, Boulain T, Dimitrov G BMJ Open. 2024; 14(4):e080235.

PMID: 38580373 PMC: 11002356. DOI: 10.1136/bmjopen-2023-080235.


Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens.

Teigen D, Opoka R, Kasirye P, Nabaggala C, Hume H, Blomberg B Pharmacoeconomics. 2023; 41(12):1603-1615.

PMID: 37462838 PMC: 10635957. DOI: 10.1007/s40273-023-01294-3.


References
1.
Makani J, Cox S, Soka D, Komba A, Oruo J, Mwamtemi H . Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania. PLoS One. 2011; 6(2):e14699. PMC: 3040170. DOI: 10.1371/journal.pone.0014699. View

2.
Hofmann M, De Montalembert M, Beauquier-Maccotta B, De Villartay P, Golse B . Posttraumatic stress disorder in children affected by sickle-cell disease and their parents. Am J Hematol. 2006; 82(2):171-2. DOI: 10.1002/ajh.20722. View

3.
Steele C, Sinski A, Asibey J, Hardy-Dessources M, Elana G, Brennan C . Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. Am J Hematol. 2018; 94(1):39-45. PMC: 6298816. DOI: 10.1002/ajh.25305. View

4.
Ware R, Davis B, Schultz W, Brown R, Aygun B, Sarnaik S . Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2015; 387(10019):661-670. PMC: 5724392. DOI: 10.1016/S0140-6736(15)01041-7. View

5.
Abdullahi S, DeBaun M, Jordan L, Rodeghier M, Galadanci N . Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial. Pediatr Neurol. 2019; 95:73-78. PMC: 6529264. DOI: 10.1016/j.pediatrneurol.2019.01.008. View